will glp 1 ever be over the counter GLP-1 Counter? Exploring the Future of Weight Loss Solutions – PlexusDx Despite FDA ruling, compounded GLP-1s

Description

Key Highlights Orforglipron (Eli Lilly) * 13.6% weight loss in Phase 2 * 2.1% HbA1c reduction * Highest efficacy among the three molecules in Phase 2 * Subsequently confirmed efficacy in Phase 3 with up to 14.7% weight loss * First and only FDA-approved oral small-molecule GLP-1 receptor agonist (Foundayo) Elecoglipron (AstraZeneca) * 11.8% weight loss * 1.9% HbA1c reduction * Strong Phase 2b results * Currently advancing into a global Phase 3 program Aleniglipron (Structure Therapeutics) * 12.1% weight loss * 1.5% HbA1c reduction * Encouraging efficacy with ongoing Phase 3 development Phase 2 Efficacy Comparison Weight Loss * Orforglipron: 13.6% * Aleniglipron: 12.1% * Elecoglipron: 11.8% HbA1c Reduction * Orforglipron: 2.1% * Elecoglipron: 1.9% * Aleniglipron: 1.5% As Structure Therapeutics expanded their testing into the ACCESS II trial and evaluated higher doses (specifically escalation protocols reaching 180 mg and 240 mg), the efficacy numbers jumped significantly

Publisher | Google Scholor Kallassy J, Gagnon E, Rosenberg D, Silbart LK, McManus SA

Experimental & Molecular Medicine, 49 (5), e338

Speak with a healthcare professional to discuss the risks versus benefits of taking Ozempic for diabetes or weight loss in consideration of your unique situation

The pressure point for food manufacturers may not be indulgence itself, but low-quality, automatic indulgence the mindless snacking habits that once drove huge volumes across confectionery, bakery and savoury snacks